Alyeska Investment Group, L.P. Insulet Corp Transaction History

Alyeska Investment Group, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$127.77 - $221.42 $12 Million - $20.8 Million	94,018 New	94,018 $20.4 Million
Q4 2022 Feb 14, 2023	BUY	$212.22 - $313.46 $28.6 Million - $42.2 Million	134,757 New	134,757 $39.7 Million
Q3 2020 Nov 16, 2020	SELL	$192.55 - $236.59 $12.6 Million - $15.5 Million	-65,316 Reduced 47.48%	72,251 $17.1 Million
Q2 2020 Aug 14, 2020	BUY	$159.17 - $224.73 $21 Million - $29.7 Million	131,970 Added 2357.87%	137,567 $26.7 Million
Q1 2020 May 15, 2020	SELL	$130.01 - $216.44 $21.2 Million - $35.2 Million	-162,814 Reduced 96.68%	5,597 $927,000
Q3 2018 Nov 14, 2018	BUY	$81.43 - $108.13 $13.7 Million - $18.2 Million	168,411 New	168,411 $17.8 Million

659

63.5M

385K

773K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $16.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.